HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N F Myasoedov Selected Research
N F Myasoedov Research Topics
Disease
5
Body Weight (Weight, Body)
12/2019 - 01/2012
4
Ischemia
05/2021 - 12/2006
4
Brain Ischemia (Cerebral Ischemia)
03/2020 - 09/2008
4
Hypercholesterolemia
11/2017 - 11/2013
4
Ulcer
04/2016 - 06/2002
4
Hyperglycemia
07/2013 - 05/2011
3
Ischemic Stroke
05/2021 - 03/2003
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2018 - 11/2015
2
Stroke (Strokes)
05/2021 - 03/2020
2
Atrophy
01/2021 - 06/2020
2
Stomach Ulcer (Gastric Ulcer)
04/2016 - 01/2015
2
Neoplasms (Cancer)
07/2015 - 10/2006
2
Anxiety Disorders (Anxiety Disorder)
01/2015 - 04/2001
2
Pain (Aches)
01/2007 - 01/2003
2
Pheochromocytoma
03/2003 - 04/2002
1
Traumatic Brain Injuries (Traumatic Brain Injury)
03/2020
1
Shock
06/2019
1
Hypersensitivity (Allergy)
04/2019
1
Parkinsonian Disorders (Parkinsonism)
05/2017
1
Wounds and Injuries (Trauma)
09/2016
1
Burns
09/2016
1
Weight Loss (Weight Reduction)
06/2016
1
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2016
1
Asthenia
01/2015
1
Somatoform Disorders (Somatoform Disorder)
01/2015
1
Cardiotoxicity
01/2015
1
Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
11/2013
1
Diabetes Mellitus
07/2013
1
Carcinogenesis
03/2013
1
Infarction (Infarctions)
12/2006
1
Pathologic Processes
05/2005
1
Bradycardia
03/2003
Drug/Important Bio-Agent (IBA)
19
Peptides (Polypeptides)
IBA
05/2021 - 04/2002
15
Pro-Gly-Pro- ACTH (4-7)
IBA
05/2021 - 04/2002
5
TP 7
IBA
06/2019 - 04/2001
5
prolyl-glycyl-proline
IBA
03/2018 - 07/2013
5
Anticoagulants
IBA
11/2017 - 07/2012
3
Messenger RNA (mRNA)
IBA
05/2021 - 01/2015
3
Nootropic Agents (Nootropics)
IBA
05/2021 - 04/2002
3
Corticosterone
IBA
01/2021 - 01/2012
3
Proteins (Proteins, Gene)
FDA Link
03/2020 - 01/2015
3
Arg-Pro-Gly-Pro
IBA
03/2018 - 07/2012
3
Blood Glucose (Blood Sugar)
IBA
11/2015 - 09/2012
2
Glutamic Acid (Glutamate)
FDA Link
03/2020 - 05/2016
2
prolylarginine
IBA
03/2018 - 09/2012
2
Cholesterol
IBA
11/2017 - 11/2015
2
Triglycerides (Triacylglycerol)
IBA
11/2017 - 11/2015
2
Cytokines
IBA
04/2016 - 01/2015
2
Hemostatics (Antihemorrhagics)
IBA
11/2015 - 11/2013
2
prolyl-glycyl-prolyl-leucine
IBA
11/2014 - 11/2013
2
glycylproline (Gly-Pro)
IBA
11/2013 - 07/2013
2
Enzymes
IBA
10/2006 - 04/2001
1
Interleukin-6 (Interleukin 6)
IBA
05/2021
1
Latex
IBA
04/2019
1
Proline (L-Proline)
FDA Link
03/2018
1
prolyl-prolyl-glycine
IBA
03/2018
1
prolylleucine
IBA
03/2018
1
LDL Cholesterol
IBA
11/2017
1
Tuftsin
IBA
05/2017
1
ACTH (4-10)
IBA
05/2017
1
Oxidopamine (6 Hydroxydopamine)
IBA
05/2017
1
phenylalanyl- asparginyl- alanyl- prolinamide
IBA
06/2016
1
RNA-Binding Protein FUS
IBA
05/2016
1
Acetic Acid (Vinegar)
FDA Link
Generic
04/2016
1
Prealbumin (Transthyretin)
IBA
01/2016
1
Carbohydrates
IBA
11/2015
1
Fats
IBA
11/2015
1
Lipoproteins (Lipoprotein)
IBA
11/2015
1
Pyrimidine Nucleosides
IBA
07/2015
1
Nucleosides
IBA
07/2015
1
Uracil
IBA
07/2015
1
Interleukin-10 (Interleukin 10)
IBA
01/2015
1
Interleukin-8 (Interleukin 8)
IBA
01/2015
1
Interleukin-4 (Interleukin 4)
IBA
01/2015
1
phenazepam
IBA
01/2015
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2015
1
Ethanol (Ethyl Alcohol)
IBA
01/2015
1
Anti-Anxiety Agents (Anxiolytics)
IBA
01/2015
1
Interleukin-2 (IL2)
IBA
01/2015
1
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2014
1
leucylproline
IBA
11/2013
1
Leucine (L-Leucine)
FDA Link
11/2013
1
prolylglycine
IBA
07/2013
1
arginylarginine (Arg-Arg)
IBA
07/2013
1
arginylproline
IBA
07/2013
1
leucylleucine (Leu-Leu)
IBA
07/2013
1
arginyl-glycyl-proline
IBA
07/2013
1
glycyl-prolyl-arginyl-proline
IBA
07/2013
1
Oligopeptides
IBA
03/2013
1
Arginine (L-Arginine)
FDA Link
09/2012
1
glycyl-prolyl-arginine
IBA
05/2011
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2008
1
Tritium
IBA
10/2006
1
Estrogens (Estrogen)
FDA Link
10/2006
1
Steroids
IBA
10/2006
1
Aromatase (CYP19)
IBA
10/2006
1
Radioisotopes (Radionuclides)
IBA
10/2006
1
Fluorescent Dyes (Fluorescent Probes)
IBA
03/2003
Therapy/Procedure
7
Intranasal Administration
04/2016 - 12/2006
4
Therapeutics
09/2016 - 04/2001